Influenza B, External Run Control, Low (6 X 1 mL) -  Log in for Price

Influenza B Low External Run Control (6 x 1mL)

Catalog# NATFLUB-ERCL
Product Information:
    • Product Type: Control
    • Volume: 1.0mL
    • Units/Pack: 6
    • Storage Condition: 2-8°C
    • Hazardous Information: Non-Infectious
    • Matrix: Purified protein matrix treated with 0.09% sodium azide
    • Target: 28 to 31 Ct
    • Product Type: Control
  • Classification/ Permits:
    RUO
    Learn More

    For Research Use Only. Not for use in Diagnostic Procedures.

    X

ZeptoMetrix external quality controls and verification panels have demonstrated performance on a variety of molecular platforms. Based upon the platform and assay’s product configuration, including but not limited to fill volumes and concentrations of analytes, we recommend our NATtrol™ Influenza B Low External Run Control to be used in conjunction with the Focus Simplexa™ system or a real-time PCR thermal cycler.

  • Formulated with purified, intact organisms
  • Organisms are chemically modified to render them noninfectious
  • Refrigerator stable—store between 2 and 8°C
  • Purified protein matrix treated with 0.09% sodium azide
  • 6 x 1.0 mL vials
  • Target: 28 to 31 cycle threshold

*Pat.: http://www.zeptometrix.com/patent-information/

NATtrol™ products are ready-to-use, inactivated full process controls designed to evaluate performance of molecular tests. They can be used for verification of assays, training of laboratory personnel and to monitor assay-kit lot performance. NATtrol™ products contain intact organisms and should be run in a manner similar to clinical specimens.

For Research Use Only. Not for use in diagnostic procedures. Quality control materials should be used in accordance with local, state, federal, and accreditation requirements. This product is not intended to replace the manufacturer's controls provided with the assay. Propagation or commercialization are prohibited without prior written consent from Antylia Scientific.

When used as a control for nucleic acid tests, the same protocols as those used to amplify extracted clinical specimens should be employed.

The suitability and performance characteristics should be determined by your laboratory for each intended usage.

Welcome To